These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23913810)

  • 21. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status.
    Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting p73 in cancer.
    Maas AM; Bretz AC; Mack E; Stiewe T
    Cancer Lett; 2013 May; 332(2):229-36. PubMed ID: 21903324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.
    Sayan AE; Roperch JP; Sayan BS; Rossi M; Pinkoski MJ; Knight RA; Willis AE; Melino G
    Ann N Y Acad Sci; 2007 Jan; 1095():315-24. PubMed ID: 17404044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functions, divergence and clinical value of TAp73 isoforms in cancer.
    Logotheti S; Pavlopoulou A; Galtsidis S; Vojtesek B; Zoumpourlis V
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):511-34. PubMed ID: 23592418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
    Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
    Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p73 isoforms meet evolution of metastasis.
    Logotheti S; Pavlopoulou A; Marquardt S; Takan I; Georgakilas AG; Stiewe T
    Cancer Metastasis Rev; 2022 Dec; 41(4):853-869. PubMed ID: 35948758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TAp73α is Upregulated in the Most Common Human Cancers].
    Iscan E; Karakülah G; Ekin U; Ozturk M; Uzuner H; Suner A
    Mol Biol (Mosk); 2022; 56(2):320. PubMed ID: 35403622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p73: in silico evidence for a putative third promoter region.
    Sayan AE; Rossi M; Melino G; Knight RA
    Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of p53, p63, and p73 to the developmental diseases and cancer.
    Tomkova K; Tomka M; Zajac V
    Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
    Anselmo NP; Rey JA; Almeida LO; Custódio AC; Almeida JR; Clara CA; Santos MJ; Casartelli C
    Genet Mol Res; 2009 Oct; 8(4):1257-63. PubMed ID: 19876867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
    Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
    Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
    Lucena-Araujo AR; Kim HT; Thomé C; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Glória AB; Chauffaille Mde L; Athayde M; Chiattone CS; Mito I; Bendlin R; Souza C; Bortolheiro C; Coelho-Silva JL; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Blood; 2015 Nov; 126(20):2302-6. PubMed ID: 26429976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.
    Ferru A; Denis S; Guilhot J; Gibelin H; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
    Eur J Surg Oncol; 2006 Mar; 32(2):228-30. PubMed ID: 16290057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms].
    Vilgelm AE; Zaika AI; Prasolov VS
    Mol Biol (Mosk); 2011; 45(1):180-97. PubMed ID: 21485507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unifying the p73 knockout phenotypes: TAp73 orchestrates multiciliogenesis.
    Napoli M; Flores ER
    Genes Dev; 2016 Jun; 30(11):1253-4. PubMed ID: 27298333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulating the genome surveillance system: miRNAs and the p53 super family.
    Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
    Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.